# The PROTEMBO C Trial

> **NCT04618718** · NA · COMPLETED · sponsor: **Protembis GmbH** · enrollment: 64 (actual)

## Conditions studied

- Valvular Heart Disease

## Interventions

- **DEVICE:** cerebral embolic protection during TAVR

## Key facts

- **NCT ID:** NCT04618718
- **Lead sponsor:** Protembis GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-07-31
- **Primary completion:** 2022-11-23
- **Final completion:** 2022-11-23
- **Target enrollment:** 64 (ACTUAL)
- **Last updated:** 2025-05-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04618718

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04618718, "The PROTEMBO C Trial". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT04618718. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*